MOUNTAIN VIEW, Calif., July 15, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that is has expanded its Reporting and Analysis Services (RAS) offerings to include preclinical and statistics, and data management. Both new business units will report under John E. Murphy, DrPH, Senior Vice President of Consulting Services.
